Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. Risks and uncertainties related to the acquisition of King by Pfizer that could cause results to differ from expectations include: uncertainties as to the timing of the merger; the possibility that a governmental entity may prohibit or delay the consummation of the merge
r; and the risk of shareholder litigation, includin
g the disposition of currently pending litigation, in conne ...[+++]ction with the merger.